For the Inventor, By the Inventor

Enter assignee name

Rhone-Poulenc Rorer S.a.

Calculating rank

USPTO Granted Patents = 247

Trademarks = 5

Forward Citations = 3,005

Loading Chart...

Loading Chart...

330 inventors (with patents filed for the assignee):

Jean-Dominique Bourzat (29 out of 51 patents)

Serge Mignani (24 out of 70 patents)

Alain Commercon (23 out of 40 patents)

4. Franco Manfre (18 out of 19 patents)

5. Patrick Jimonet (17 out of 23 patents)

6. Herve Bouchard (14 out of 28 patents)

7. Alain Commercedillaon (14 out of 15 patents)

8. Jean-Claude Aloup (13 out of 23 patents)

9. Marc Capet (12 out of 41 patents)

10. Dominique Damour (12 out of 19 patents)

11. Claude Guyon (12 out of 24 patents)

12. Patrick Leon (12 out of 24 patents)

13. Marie-Christine Dubroeucq (12 out of 27 patents)

14. Michel Barreau (10 out of 22 patents)

15. Arielle Genevois-Borella (9 out of 25 patents)

Core Competencies:

Adenoviral Vectors

Taxoids

Recombinant Proteins

Pharmaceutical Compositions

Farnesyl Transferase Inhibitors

Peptides

Nucleic Acids

Biosynthesis

Canine Origin

Nanoparticles

Antitumor Compositions

Microspheres

247 patents: Sort by Forward Citations

1. 6312946 - Viable contaminant particle free adenoviruses, their prepartion and use (2001-11-06),

2. 6294377 - Adenoviral vectors of canine origin (2001-09-25),

3. 6291679 - Process for preparing benzoperhydroisoindole compounds (2001-09-18),

4. 6288075 - Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same (2001-09-11),

5. 6287762 - Purification of a triple helix formation with an immobilized oligonucleotide (2001-09-11),

6. 6261807 - Method for preparing a recombinant adenovirus genome (2001-07-17),

7. 6239270 - Nucleic acids encoding human calcium sensor protein (2001-05-29),

8. 6235497 - Recombinant expression of the rat vesicular acetylcholine transporter (2001-05-22),

9. 6210879 - Method for diagnosing schizophrenia (2001-04-03),

10. 6207675 - Pyrrole derivatives, their preparation and pharmaceutical compositions containing them (2001-03-27),

11. 6200798 - Defective recombinant adenoviruses with inactivated IVa2 gene (2001-03-13),

12. 6197980 - 4-Acetoxy-2&agr;-benzoyloxy-5&bgr;,20-epoxy-1&bgr;,7&bgr;,10&bgr;-trihydroxy-9-oxo-11-taxen-13&agr;-yl(2R,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate trihydrate (2001-03-06),

13. 6194582 - Taxoids, their preparation and pharmaceutical compositions containing them (2001-02-27),

14. 6194426 - 5,6,7,8 tetrahydroindolizines derivatives (2001-02-27),

15. 6187746 - Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof (2001-02-13),

Company Overview

Rhone-Poulenc Rorer S.a., headquartered in Antony, France, is a prominent player in the biopharmaceutical sector, specializing in the development and manufacturing of innovative therapeutic solutions. The company focuses on advanced technologies such as adenoviral vectors, which are pivotal in gene therapy and vaccine development. Additionally, it explores various core technology topics including taxoids, recombinant proteins, and pharmaceutical compositions, contributing to the advancement of healthcare through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

247 Patents

#2 in Antony

#100 in France

#3,525 in the World

Rhone-Poulenc Rorer S.a.

Forward Citations = 3,005

330 inventors:

Jean-Dominique Bourzat (29 out of 51 patents)

Serge Mignani (24 out of 70 patents)

Alain Commercon (23 out of 40 patents)

4. Franco Manfre (18 out of 19 patents)

5. Patrick Jimonet (17 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rhone-Poulenc Rorer S.a.. Retrieved from https://idiyas.com/company/rhone-poulenc-rorer-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…